An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used medicines but with less frequent injections.
Source
Stat News
Opens original article in a new tab
Doctronic, the startup behind a provocative experiment in Utah to renew drug prescriptions with a chatbot, has raised $40 million.
Insmed hopes to convert Arikayce's accelerated approval to a full approval.
Lyme is found in almost a half-million Americans each year. A new vaccine shows some promise.
Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup.